3821 studies found for:    "Lung Diseases, Obstructive"
Show Display Options
Rank Status Study
21 Completed HR-lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease
Condition: Asthma, Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Ivabradine (Procoralan);   Drug: Placebo
22 Completed Genetic Factors That Influence Chronic Obstructive Pulmonary Disease in Hispanics
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Obstructive
Intervention:
23 Completed Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Obstructive
Intervention:
24 Completed Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases;   Lung Diseases, Obstructive
Intervention:
25 Recruiting T Lymphocyte Cells in Individuals Experiencing an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Obstructive
Intervention:
26 Completed Comparison of Two Programs to Encourage Physical Activity in Individuals With Chronic Obstructive Pulmonary Disease
Conditions: Pulmonary Disease, Chronic Obstructive;   Lung Diseases, Obstructive
Interventions: Behavioral: Lifestyle Activity Program;   Behavioral: Exercise Program
27 Withdrawn Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension
Condition: Chronic Obstructive Lung Disease
Intervention: Drug: Tadalafil
28 Completed
Has Results
Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium bromide;   Drug: Placebo
29 Completed
Has Results
Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: aclidinium bromide
30 Completed
Has Results
Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Aclidinium bromide
31 Completed Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate;   Drug: Formoterol Fumarate
32 Completed To Assess the Long-term Safety, Efficacy and Tolerability of Inhaled Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium bromide;   Drug: Placebo
33 Completed Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate;   Drug: Aclidinium Bromide;   Drug: Formoterol Fumarate;   Drug: placebo
34 Completed Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Aclidinium/Formoterol;   Drug: Formoterol
35 Completed Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate;   Drug: Aclidinium Bromide;   Drug: Formoterol Fumarate;   Drug: Placebo
36 Completed Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Lung Disease
Intervention:
37 Completed Non-invasive Ventilation System in Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Airflow Obstruction, Chronic;   Chronic Obstructive Airway Disease;   Chronic Obstructive Lung Disease
Intervention: Device: Breathe Technologies Noninvasive Open Ventilation (NIOV™) System
38 Completed
Has Results
The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Indacaterol 300 μg;   Drug: Placebo
39 Recruiting Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
40 Recruiting Cognitive Status in Chronic Obstructive Pulmonary Disease's Patients
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: Cognitive assessment

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years